AMANDA COX: Open Payments
NPI 1154993814 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 4 payments from 4 companies in 2025. Trend: 2023 $251 · 2024 $144 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $118 |
| Biocon Biologics Inc | 1 | $43 |
| Astellas Pharma US Inc | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: JEMPERLI, Ogivri, Veozah, KEYTRUDA.
Industry payments across NV — which companies pay providers there.
